In a corneal micropocket assay, the Matrigel model, and in an experimental tumor model, PAF-R antagonists significantly reduced VEGF-related and tumor-related angiogenesis [18], [19], [38]–[40]. The gene discussed is PTAFR; the disease is neoplasm.